Log in
Start free trial
Book a demo
Product
Media Database
Find the right journalists
Online Newsroom
Shape your own narrative
Press Release Creator
Create and send press releases
Media Monitoring
Track every single online mention
Media Pitching Tool
Contact recommendations & stats
PR Reports
Showcase the impact of your work
PR CRM
Manage contacts in easy way
AI PR Software
Use AI to save time on your workflow
Social Media Listening
Get a full overview of your brand's presence
Pricing
Top journalists
Top outlets
Log in
Start free trial
Media Database
>
Hannah Kuchler
Hannah Kuchler
Global Pharma Editor / Global Pharmaceuticals Correspondent at
Financial Times
Contact this person
Email address
i*****@*******.com
Get email address
Influence score
53
Phone
(XXX) XXX-XXXX
Get mobile number
Location
United Kingdom
Languages
English
Covering topics
Health & Medicine
View more media outlets and journalists by signing up to Prowly
View latest data and reach out all from one place
Sign up for free
Recent Articles
ft.com
Novo Nordisk partners with US biotech to boost pipeline of new obesity drugs
Potential ‘best-in-class’ medicine targets conditions that cost US health system billions a year
7 months ago
ft.com
Biotech billionaire Christian Angermayer: ‘Psychedelics can take aw...
The entrepreneur’s London penthouse is filled with bitcoin-inspired artworks, trippy sculptures and dinosaur skulls. Its an insight into his interest in exploring new frontiers
7 months ago
ft.com
Zealand Pharma says obesity drug deal with Roche will help it stay ...
Danish biotech is developing petrelintide in partnership with Swiss pharma group
7 months ago
ft.com
US patients lose access to cheaper weight-loss drugs as market for ...
Pharmacies told to stop making custom versions of Wegovy and Zepbound after shortages declared officially over
8 months ago
ft.com
Fund for struggling biotechs takes aim at ‘tragedy’ for shareholders
Alis Biosciences then plans to list and offer big investors an easy way to spread their bets
8 months ago
ft.com
Eli Lilly’s new obesity pill lowers blood sugar and aids weight loss
Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%
8 months ago
ft.com
NHS signs deal with Scancell in ambitious skin cancer trial
Move comes as government seeks to boost UK’s standing as drugs research leader
8 months ago
ft.com
Swiss drugmaker Novartis to invest $23bn in US manufacturing and R&D
Pharma group builds out American supply chains as part of preparations for potential US tariffs
8 months ago
ft.com
UK promises rapid review of NHS drug-pricing rebate
Under the scheme, drugmakers discount price of medicines sold in bulk to healthcare system
8 months ago
ft.com
Former UK IPO star Nanopore admits it is a takeover target
DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time
9 months ago
ft.com
Higher medicine sales tax makes UK ‘uninvestable’, warn drugmakers
Industry lobby group calls for action from government ahead of summit in April
9 months ago